Treatment of cancer - targeted biological therapies Flashcards
1
Q
Limitations of conventional cytotoxic chemotherapy
A
- Lack of specificity
- Toxicity
- Lack of effectiveness
- Lack of individualisation
2
Q
Classification of targeted therapies in cancer
A
- Cell cycle signalling
- Immune checkpoint inhibitors
- Angiogenesis
- Epigenetic modifiers
3
Q
Which cancers are associated with EGFR mutations
A
Mutations that up-regulate the EGFR or overactivity have been associate with:
- Squamous-cell carcinoma of lung
- Anal cancers
- Glioblastoma
- Epithelial tumours of the head and neck
4
Q
Anti-cancer therapies of the EGFR
A
EGFR identification as an oncogene led to development of:
1. Monoclonal antibody inhibitors - Cetuximab, panitumumab = block the extracellular ligand binding domain
- Small molecule kinase inhibitors - gefitinib, erlotinib = inhibit EGFR tyrosine kinase activity on the cytoplasmic side
5
Q
Side effects associated with EGFR inhibitors
A
- The most common adverse effect of EGFR inhibitors, found in more 90% of patients, is a papulopustular rash that spreads across the face and torso
- Other side adverse effects: diarrhoea, nausea, vomiting, fatigue, dehydration
6
Q
Side effects of angiogenic inhibitors
A
Bleeding Increased BP Rash and/or itchy skin Diarrhoea Fatigue Low blood counts
7
Q
Chemotherapy
- Target
- Method
- Side effects
- Treats
A
- Target - Proliferating cells
- Method - Drugs
- Side effects - Hair loss, reduced immune system, nausea, vomiting
- Treats - More than one part of the body, sometimes whole body
8
Q
Radiotherapy
- Target
- Method
- Side effects
- Treats
A
- Target - Tumour
- Method - High energy waves
- Side effects - Sores, swelling, fatigue, hair loss, dryness
- Treats - Single part of the body
9
Q
Biological therapy
- Target
- Method
- Side effects
- Treats
A
- Target - Immune cells
- Method - Drugs
- Side effects - Flu-like symptoms
- Treats - Specific targets